Frequently Asked Questions
The monogenic disease testing market is projected to grow at a CAGR of 11% during the forecast period of 2022-2029.
The factors such as the rising prevalence of monogenic disorders around the world will provide ample opportunities are the major growth driving factors.
The Monogenic Disease Testing Market is segmented by Test Type, Disease Type & End Use.
North America dominates the monogenic disease testing market due to the high degree of intelligence and growing awareness amongst people regarding to monogenic disease testing procedures.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the presence of a substantial number of organizations that are focusing on disease management.
